Aging population drives China's healthcare demand

Chronic disease pressures and rising wellness trends are reshaping the sector.

The rapid rise in chronic diseases and aging demographics is placing unprecedented strain on China’s healthcare system, according to Lin Xiao, Sales Manager at Xi'an Haoxuan Bio-tech Co., Ltd.

Speaking on the sidelines of API China 2025, Lin said, “I think one of the most pressing changes is raising demand for high quality healthcare service driven by an ageing population and increasing chronic disease. They put significant pressure on the system to deliver efficient and the invitation solution, particularly in preventive care and the natural health products.”

Lin noted that despite the strain, significant growth potential remains untapped. “There is immense potential in low-range Traditional Chinese Medicine and the nature plant attracted with modern scientific validation,” she said, adding that rising wellness awareness is creating opportunities for plant-based solutions that support long-term health.

To meet these needs, Lin said the company is “investing in R&D to create standardised, high purity ingredients for preventive health solutions.”